| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 15610370 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 120 journal articles in the PubMed database | Email to a friend | | |
| Abelson MB, Ferzola NJ, McWhirter CL, et al.
Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Pediatr Allergy Immunol 2004 Dec; 15(6):551-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Crampton HJ
Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2003 Jul; 25(7):1975-87.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | D'Arienzo PA, Leonardi A, Bensch G
Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2002 Mar; 24(3):409-16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Greiner JV, Minno G
A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2003 Jul; 25(7):1988-2005.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Greiner JV, Mundorf T, Dubiner H, et al.
Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Ophthalmol 2003 Dec; 136(6):1097-105.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Abelson MB, Chapin MJ, Kapik BM, et al.
Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Arch Ophthalmol 2003 May; 121(5):626-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Crampton HJ
A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2002 Nov; 24(11):1800-8.
Abstract | Full Citation | Find Related Articles | | Spangler DL, Abelson MB, Ober A, et al.
Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2003 Aug; 25(8):2245-67.
Abstract | Full Citation | Find Related Articles | | Spangler DL, Bensch G, Berdy GJ
Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2001 Aug; 23(8):1272-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
